Unknown

Dataset Information

0

Identification of a de novo splicing variant in the Coffin-Siris gene, SMARCE1, in a patient with Angelman-like syndrome.


ABSTRACT: BACKGROUND:Patients affected by Angelman syndrome (AS) present severe intellectual disability, lack of speech, ataxia, seizures, abnormal electroencephalography (EEG), and a characteristic behavioral phenotype. Around 10% of patients with a clinical diagnosis of AS (AS-like) do not have an identifiable molecular defect. Some of these patients harbor alternative genetic defects that present overlapping features with AS. METHODS:Trio whole-exome sequence was performed on patient and parent's DNA extracted from peripheral blood. Exome data were filtered according to a de novo autosomal dominant inheritance. cDNA analysis was carried out to assess the effect of the splice site variant. RESULTS:We identified a novel heterozygous SMARCE1 splicing variant that leads to an exon skipping in a patient with an Angelman-like phenotype. Missense variants in the SMARCE1 gene are known to cause Coffin-Siris syndrome (CSS), which is a rare congenital syndrome. Clinical reevaluation of the patient confirmed the presence of characteristic clinical features of CSS, many of them overlapping with AS. CONCLUSIONS:Taking into account the novel finding reported in this study, we consider that CSS should be added to the expanding list of differential diagnoses for AS.

SUBMITTER: Aguilera C 

PROVIDER: S-EPMC6382443 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of a de novo splicing variant in the Coffin-Siris gene, SMARCE1, in a patient with Angelman-like syndrome.

Aguilera Cinthia C   Gabau Elisabeth E   Laurie Steve S   Baena Neus N   Derdak Sophia S   Capdevila Núria N   Ramirez Ariadna A   Delgadillo Veronica V   García-Catalan Maria Jesus MJ   Brun Carme C   Guitart Miriam M   Ruiz Anna A  

Molecular genetics & genomic medicine 20181211 1


<h4>Background</h4>Patients affected by Angelman syndrome (AS) present severe intellectual disability, lack of speech, ataxia, seizures, abnormal electroencephalography (EEG), and a characteristic behavioral phenotype. Around 10% of patients with a clinical diagnosis of AS (AS-like) do not have an identifiable molecular defect. Some of these patients harbor alternative genetic defects that present overlapping features with AS.<h4>Methods</h4>Trio whole-exome sequence was performed on patient and  ...[more]

Similar Datasets

| S-EPMC10655513 | biostudies-literature
| S-EPMC6900373 | biostudies-literature
| S-EPMC5870868 | biostudies-literature
| S-EPMC5641751 | biostudies-literature
| S-EPMC4789813 | biostudies-literature
| S-EPMC8427664 | biostudies-literature
2021-07-22 | GSE180423 | GEO
| S-EPMC8738766 | biostudies-literature
| S-EPMC8082577 | biostudies-literature
| S-EPMC10483805 | biostudies-literature